Tvardi Therapeutics Inc.

NASDAQ: TVRD · Real-Time Price · USD
24.30
0.51 (2.14%)
At close: Aug 15, 2025, 3:59 PM
24.00
-1.23%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tvardi Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
2.57M 1.46M 2.56M 991K 2.13M n/a 4.87M
Cost of Revenue
n/a n/a 73K 77K 620K n/a 1.62M
Gross Profit
2.57M n/a 2.48M 914K 1.51M n/a 3.25M
Operating Income
-2.39M -6M -6.3M -16.21M -29.67M -4.66M -28.9M
Interest Income
n/a 421K 766K 689K n/a 313K 866K
Pretax Income
-4.91M -8.08M -12.48M -20.02M -30.7M -4.35M -28.03M
Net Income
-4.91M -7.68M -12.48M -20.02M -30.7M -4.35M -28.03M
Selling & General & Admin
4.64M 6.83M 6.4M 6.37M 6.79M 682K 6.72M
Research & Development
319K 171K 1.36M 9.27M 21.96M 3.98M 25.42M
Other Expenses
n/a 454K 1.02M 1.49M 2.43M n/a n/a
Operating Expenses
4.96M 7.46M 8.78M 17.13M 31.18M 4.66M 32.15M
Interest Expense
2.87M 2.62M 1.96M 1.91M 1.98M n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.96M 7.46M 8.86M 17.2M 31.8M 4.66M 33.76M
Income Tax Expense
n/a -398K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
9.36M 1.52M 1.52M 1.52M 9.36M 9.36M 1.51M
Shares Outstanding (Diluted)
9.36M 1.52M 1.52M 1.52M 9.36M 9.36M 1.51M
EPS (Basic)
-0.52 -5.04 -8.19 -13.17 -3.28 -0.47 -18.61
EPS (Diluted)
-0.52 -5.04 -8.19 -13.17 -3.28 -0.47 -18.61
EBITDA
-2.04M -5.46M -10.44M -18.03M -28.67M -3.32M -27.51M
EBIT
-2.04M -5.46M -10.52M -18.11M -28.71M -3.35M -28.03M
Depreciation & Amortization
n/a n/a 73K 77K 42K 24K 521K